A Case of Metastatic Extramammary Paget’s Disease Responding to Trastuzumab plus Paclitaxel Combination Therapy

A Case of Metastatic Extramammary Paget’s Disease Responding to Trastuzumab plus Paclitaxel Combination Therapy

There is no effective treatment for advanced extramammary Paget’s disease (EMPD). The human epidermal growth factor receptor 2 (HER2) protein is often overexpressed in EMPD. Trastuzumab is a humanized monoclonal antibody against HER2 used in the treatment of breast cancers in which HER2 is overexpre...

Full description

Bibliographic Details
Main Authors: Fumie Hanawa, Takashi Inozume, Kazutoshi Harada, Tatsuyosi Kawamura, Naotaka Shibagaki, Shinji Shimada
Format: Article
Language:English
Published: Karger Publishers 2011-10-01
Series:Case Reports in Dermatology
Subjects:
Extramammary Paget’s disease
Human epidermal growth factor receptor 2
Trastuzumab
Paclitaxel
Online Access:http://www.karger.com/Article/FullText/333002

Internet

http://www.karger.com/Article/FullText/333002

Similar Items